Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.

U. Winterfeld,Gil Klinger,Alice Panchaud,Sally Stephens,Judy Arnon,Heli Malm,Bernke te Winkel,Maurizio Clementi,Alessandra Pistelli,Eva Manakova,Georgios Eleftheriou,Paul Merlob,Yusuf Cem Kaplan,Thierry Buclin,Laura E. Rothuizen

Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study.

2015

U. Winterfeld
Gil Klinger
Alice Panchaud
Sally Stephens
Judy Arnon
Heli Malm
Bernke te Winkel
Maurizio Clementi
Alessandra Pistelli
Eva Manakova
Georgios Eleftheriou
Paul Merlob
Yusuf Cem Kaplan
Thierry Buclin
Laura E. Rothuizen

CZTIS, 3rd Faculty of Medicine, Charles University, Prague, Czech RepublicCorrespondence: U Winterfeld, Division de Pharmacologie et Toxicologie cliniques, Centre Hospitalier Universitaire Vaudois, Swiss TeratogenInformation Service, BT 06 - 6241011 Lausanne, Switzerland. Email ursula.winterfeld@chuv.chAccepted 24 September 2012. Published Online 30 November 2012.

Keywords:

Prospective cohort study
Premature birth
Gynecology
Mirtazapine
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pregnancy
Medicine
Odds ratio
Miscarriage
Gestational age
Case-control study
Statistical significance
Obstetrics

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations